genetic susceptibility development chronic obstructive pulmonary disease copd depend variation activities enzymes detoxify cigarette smoke products microsomal epoxide hydrolase mephx glutathione gst investigated polymorphisms genes association susceptibility copd copd severity genotypes NUMBER patients copd NUMBER control subjects determined polymerase chain reaction followed restriction fragment length polymorphism analysis mephx gstm1 gstt1 gstp1 genes subjects smokers exsmokers proportion genotypes significantly higher patients copd control subjects NUMBER versus NUMBER differences observed frequency polymorphic genotypes mephx gstt1 gstp1 combined analysis genetic polymorphisms mephx gstm1 gstp1 strong indicators susceptibility copd genotype combination mutant mephx allele histidine NUMBER gstm1 null homozygous gstpi isoleucine NUMBER allele frequencies homozygous mutant alleles mephx exon NUMBER genotype significantly higher patients severe copd forced expiratory volume second NUMBER predicted value proposed combination genetic variants including mutant microsomal epoxide hydrolase allele glutathione m1null homozygous isoleucine NUMBER glutathione p1 genotypes significant indicators susceptibility chronic obstructive pulmonary disease taiwanese population addition homozygous variant microsomal epoxide hydrolase exon NUMBER glutathione m1null genotype independent risk factors developing severe chronic obstructive pulmonary disease s transferase gstm1 null exon NUMBER gstmi null exon NUMBER s transferase s transferase s transferase